Publication | Closed Access

Combined anti-fibrotic and anti-inflammatory properties of JAK-inhibitors on macrophages in vitro and in vivo: Perspectives for scleroderma-associated interstitial lung disease

InflammationAntifibrotic TherapyFibrosisAutoimmune DiseaseSclerodermaLung InflammationInflammatory Lung DiseaseMedicineAnti-inflammatoryImmunologySystemic SclerodermaChronic InflammationPulmonary FibrosisAnti-inflammatory PropertiesImmunotherapyPharmacologyMatrikinesJak-stat Signaling Pathway